SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

3 Months Ended

Mar. 31, 2025

Accounting Policies [Abstract]

Schedule Of Revenue Sources Health Care Organization Table Text Block

Net service revenue by payor class as a percentage of total net service revenue for each of our operating segments, which are described in Note 8 - Segment Information, is as follows:

	For the Three-Month Periods Ended March 31,
	2025		2024
Home Health:
Medicare	36	%	38	%
Non-Medicare - Episodic-based	8	%	8	%
Non-Medicare - Non-episodic based	20	%	18	%
Hospice:
Medicare	33	%	33	%
Non-Medicare	2	%	2	%
High Acuity Care	1	%	1	%
	100	%	100	%

Schedule of Fair Value of Financial Instruments

The following details our financial instruments where the carrying value and the fair value differ (amounts in millions):

			Fair Value at Reporting Date Using
Financial Instrument	Carrying Value as of March 31, 2025		Quoted Prices in Active Markets for Identical Items (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
$450.0 million Term Loan	$	343.8	$	—	$	344.1	$	—

Schedule of Weighted-Average Shares Outstanding

The following table sets forth, for the periods indicated, shares used in our computation of weighted-average shares outstanding, which are used to calculate our basic and diluted net income attributable to Amedisys, Inc. common stockholders (amounts in thousands):

	For the Three-Month Periods Ended March 31,
	2025	2024
Weighted average number of shares outstanding - basic	32,793	32,670
Effect of dilutive securities:
Stock options	10	10
Non-vested stock and stock units	415	299
Weighted average number of shares outstanding - diluted	33,218	32,979
Anti-dilutive securities	342	388